查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1490101

富血小板血浆市场：依类型、来源、应用、地区

Platelet Rich Plasma Market, By Type, By Origin, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 184 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球富血小板血浆市场规模为5.505亿美元，预计2031年将达12.558亿美元，2024年至2031年复合年增长率为12.5%。

报告范围 报告详情
基准年 2023年 2024年市场规模 5.505 亿美元
实际资料 2019年至2023年 预测期 从2024年到2031年
预测 2024-2031 年复合年增长率： 12.50% 2031年价值预测 12.558 亿美元
图：2024 年按地区分類的富血小板血浆市场占有率(%)
富血小板血浆市场-IMG1

富血小板血浆（PRP）是从少量全血中提取的血小板浓缩物。 PRP 含有多种已知可促进组织再生的生长因子。 PRP 疗法是一种即将推出的治疗方法各种肌肉骨骼疾病（如肌腱炎、关节损伤和关节炎）的疗法。血小板分泌的生长因子会透过吸引干细胞并刺激细胞增生和分化来诱导组织癒合。随着运动伤害和退化性疾病的日益流行，PRP 已成为外科手术和组织修復药物的有前途的替代方案。

市场动态：

最近的趋势表明，由于 PRP 的再生特性，PRP 在各个治疗领域中得到了迅速采用。运动医学的成长和肌肉骨骼疾病病例的增加是该市场的主要驱动力。然而，与 PRP 程序和设备相关的高成本可能会阻碍更广泛的采用。廉价 PRP 製备套件的开发提供了重大机会。市场领导正在投资研发以扩大核准的临床适应症。例如，监管机构核准PRP 在脸部回春中的使用开闢了新的途径。

本研究的主要特点

  • 本报告详细分析了全球富血小板血浆市场，并提供了以 2023 年为基准年的预测期（2024-2031）的市场规模（百万美元）和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在收益成长机会，并说明了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球富血小板血浆市场的主要企业。
  • 主要企业包括 Arthrex, Inc.、Ester Medical、Zimmer Biomet、Terumo Corporation、Glofinn Oy、Medira Ltd.、Regen Lab SA、CollPlant、Generex Biotechnology Corporation、Estar Technologies Ltd.、Cesca Therapeutics, Inc.、ArteriCell Medical Systems、Harvest Technologies Corp.、EmCyte Corporation、T-Biotechnology Ltd. 和Isto Biologics。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球富血小板血浆市场迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球富血小板血浆市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管场景
  • 製造商收益
  • 收购和合作场景
  • 产品发布/核准
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章全球富血小板血浆市场－冠状病毒（COVID-19）大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章全球富血小板血浆市场，依类型，2019-2031

  • 纯PRP
  • PRP含有大量白血球
  • 纯脉衝频率
  • PRF含有大量白血球

第六章 全球富血小板血浆市场，依来源划分，2019-2031 年

  • 自体移植
  • 同种异体的
  • 同源基因

第七章全球富血小板血浆市场，依应用分类，2019-2031

  • 神经外科
  • 整容手术
  • 整形外科
  • 一般外科
  • 其他的

第八章全球富血小板血浆市场，按地区，2019-2031

第9章 竞争格局

  • 公司简介
    • Arthrex, Inc.
    • Ester Medical
    • Zimmer Biomet
    • Terumo Corporation
    • Glofinn Oy
    • Medira Ltd.
    • Regen Lab SA
    • CollPlant
    • Generex Biotechnology Corporation
    • Estar Technologies Ltd.
    • Cesca Therapeutics, Inc.
    • Arteriocyte Medical Systems
    • Harvest Technologies Corp.
    • EmCyte Corporation
    • T-Biotechnology Ltd.
    • Isto Biologics

第10章分析师建议

  • Wheel of Fortune
  • 分析师观点
  • Coherent Opportunity Map

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI936

The global platelet rich plasma market is estimated to be valued at USD 550.5 Mn in 2024 and is expected to reach USD 1,255.8 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 550.5 Mn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 12.50% 2031 Value Projection: US$ 1,255.8 Mn
Figure. Platelet Rich Plasma Market Share (%), By Region, 2024
Platelet Rich Plasma Market - IMG1

Platelet Rich Plasma (PRP) is an enriched concentration of platelets extracted from a small volume of whole blood. It contains several growth factors that are known to accelerate tissue regeneration. PRP therapy is an upcoming treatment for various musculoskeletal conditions such as tendonitis, joint injuries, and arthritis. The secretion of growth factors from platelets induces tissue healing by attracting stem cells and stimulating cell proliferation and differentiation. With the increasing prevalence of sports injuries and degenerative conditions, PRP is emerging as a promising alternative to surgical interventions and medications for tissue repair.

Market Dynamics:

Recent trends indicate the rapid adoption of PRP in various therapeutic areas due to its regenerative properties. Growth in sports medicine and rising cases of musculoskeletal disorders are major drivers for this market. However, high costs associated with PRP procedures and equipment may restrain wider adoption. The development of inexpensive PRP preparation kits presents significant opportunities. Market leaders are investing in R&D to expand approved clinical indications. For example, regulatory approvals for use of PRP in facial rejuvenation opens new avenues.

Key Features of the Study:

  • This report provides an in-depth analysis of the global platelet rich plasma market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global platelet rich plasma market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this Arthrex, Inc., Ester Medical, Zimmer Biomet, Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, Estar Technologies Ltd., Cesca Therapeutics, Inc., Arteriocyte Medical Systems, Harvest Technologies Corp., EmCyte Corporation, T-Biotechnology Ltd., and Isto Biologics.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global platelet rich plasma market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global platelet rich plasma market.

Detailed Segmentation-

  • By Type:
    • Pure PRP
    • Leukocyte rich PRP
    • Pure PRF
    • Leukocyte rich PRF
  • By Origin:
    • Autologous
    • Allogenic
    • Homologues
  • By Application:
    • Neurosurgery
    • Cosmetic Surgery
    • Orthopedic Surgery
    • General Surgery
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Arthrex, Inc.
    • Ester Medical
    • Zimmer Biomet
    • Terumo Corporation
    • Glofinn Oy
    • Medira Ltd.
    • Regen Lab S.A.
    • CollPlant
    • Generex Biotechnology Corporation
    • Estar Technologies Ltd.
    • Cesca Therapeutics, Inc.
    • Arteriocyte Medical Systems
    • Harvest Technologies Corp.
    • EmCyte Corporation
    • T-Biotechnology Ltd.
    • Isto Biologics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Origin
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Platelet Rich Plasma Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Platelet Rich Plasma Market, By Type, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Pure PRP
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Leukocyte rich PRP
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Pure PRF
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Leukocyte rich PRF
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Platelet Rich Plasma Market, By Origin, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Autologous
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Allogenic
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Homologues
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Platelet Rich Plasma Market, By Application, 2019 - 2031, (USD Mn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Neurosurgery
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Cosmetic Surgery
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Orthopedic Surgery
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • General Surgery
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Platelet Rich Plasma Market, By Region, 2019 - 2031, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • U.S.
      • Canada
      • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Arthrex, Inc.*
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Ester Medical
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Zimmer Biomet
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Terumo Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Glofinn Oy
    • Medira Ltd.
    • Regen Lab S.A.
    • CollPlant
    • Generex Biotechnology Corporation
    • Estar Technologies Ltd.
    • Cesca Therapeutics, Inc.
    • Arteriocyte Medical Systems
    • Harvest Technologies Corp.
    • EmCyte Corporation
    • T-Biotechnology Ltd.
    • Isto Biologics

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact